The Immune Landscape of the Human Optic Nerve Head
About the Research Project
Program
Award Type
Standard
Award Amount
$150,000
Active Dates
July 01, 2026 - June 30, 2028
Grant ID
G2026014S
Co-Principal Investigator(s)
Navita Lopez, PhD, The University of Utah
Goals
This project aims to study the properties of resident myeloid cells in the human optic nerve head and optic nerve, assess how they change in glaucoma and define the responses of other immune cell populations to better understand mechanisms of vision loss and identify new therapeutic targets.
Summary
We will study the properties of resident myeloid cells in the human optic nerve head and optic nerve, will assess how they change in glaucoma and define the responses of other immune cell populations. By mapping these cells and defining their molecular signatures, we aim to uncover how neuroimmune responses may have protective or detrimental effects and identify new targets to protect vision.
Unique and Innovative
This study will generate the first high-resolution immune atlas of the human ONH, will reveal previously uncharacterized specialized immune cell niches, and will define how these are remodeled in glaucoma. By integrating molecular identity of immune cell populations with anatomical localization, this study establishes a new framework for understanding neuroimmune interactions in human glaucoma and opens avenues for targeting local immune mechanisms to protect vision.
Foreseeable Benefits
Successful completion of this project will provide the first spatially resolved map of immune cell diversity in the human optic nerve head and reveal how these populations are altered in glaucoma. This will provide an important resource for the research community that will directly inform translational studies aimed at targeting local immune mechanisms to protect retinal ganglion cells. This could lead to new ways to detect, prevent, or treat glaucoma by improving our understanding of how immune cells contribute to optic nerve damage and vision loss.
Related Grants
National Glaucoma Research
Understanding Optic Nerve Head Astrocyte Contributions to Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Evan Cameron, PhD
Current Organization
Cleveland Clinic - Lerner Research Institute
Understanding Optic Nerve Head Astrocyte Contributions to Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Evan Cameron, PhD
Current Organization
Cleveland Clinic - Lerner Research Institute
National Glaucoma Research
Exploring Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Qi Cui, MD, PhD
Current Organization
University of Pennsylvania, Perelman School of Medicine
Exploring Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Qi Cui, MD, PhD
Current Organization
University of Pennsylvania, Perelman School of Medicine
National Glaucoma Research
Reducing Inflammation to Protect Vision in Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Cátia Gomes, PhD
Current Organization
Indiana University School of Medicine
Reducing Inflammation to Protect Vision in Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Cátia Gomes, PhD
Current Organization
Indiana University School of Medicine